EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives

Rushil Harryparsad, Bahiah Meyer, Ongeziwe Taku, Myrna Serrano, Pai Lien Chen, Xiaoming Gao, Anna-Lise Williamson, Celia Mehou-Loko, Florence Lefebvre d'Hellencourt, Jennifer Smit, Jerome Strauss iD, Kavita Nanda und 6 weitere

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0294285 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2023. Verfasst von Rushil Harryparsad und 17 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa. Hauptthemen laut MEDLINE: Sexually Transmitted Diseases, Trichomonas vaginalis, HIV Infections, Chlamydia Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Carnegie Corporation of New York.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

South Africa is among the countries with the highest prevalence of sexually transmitted infections (STIs), including Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). In 2017, there were an estimated 6 million new CT, 4.5 million NG and 71 000 Treponema pallidum infections among South African men and women of reproductive age.

Methods

We evaluated STI prevalence and incidence and associated risk factors in 162 women aged 18–33 years old, residing in eThekwini and Tshwane, South Africa who were part of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial. Women were randomised to use depot medroxyprogesterone acetate (n = 53), copper intrauterine device (n = 51), or levonorgestrel (n = 58) implant. Lateral vaginal wall swab samples were collected prior to contraceptive initiation and at months one and three following contraceptive initiation for STI testing.

Results

There were no significant differences in STI incidence and prevalence across contraceptive groups. At baseline, 40% had active STIs (CT, NG, Trichomonas vaginalis (TV), Mycoplasma genitalium (MG) or herpes simplex virus-2 shedding across all age groups– 18–21 years (46%), 22–25 years (42%) and 26–33 years (29%). The incidence of STIs during follow-up was exceptionally high (107.9/100 women-years [wy]), with younger women (18–21 years) more likely to acquire CT (75.9/100 wy) compared to 26–33 year olds (17.4/100 wy; p = 0.049). TV incidence was higher in the 26–33 year old group (82.7/100 wy) compared to the 18–21 year olds (8.4/100 wy; p = 0.01).

Conclusions

Although the study participants received extensive counselling on the importance of condom use, this study highlights the high prevalence and incidence of STIs in South African women, especially amongst young women, emphasising the need for better STI screening and management strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sexually Transmitted DiseasesTrichomonas vaginalisHIV InfectionsChlamydia InfectionsMaleHumansFemaleAdolescentYoung AdultAdultSouth AfricaContraceptive AgentsPrevalenceIncidenceChlamydia trachomatisNeisseria gonorrhoeae

Substanzen

Contraceptive Agents

Autor:innen und Institutionen

  • Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
  • Virginia Commonwealth University, Richmond, Virginia, United State of America.
  • FHI 360, Durham, North Carolina, United States of America.
  • MRU, University of the Witwatersrand, Durban, South Africa.
  • Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, PA, United States of America.
  • Setshaba Research Centre, Pretoria, South Africa.

ORCID-Profile: Jerome Strauss, Khatija Ahmed, Lindi Masson

Förderung

  • NICHD NIH HHS
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • Carnegie Corporation of New York
  • South African National Research Foundation
  • Australian National Health and Medical Research Council
  • Bill and Melinda Gates Foundation
  • United States Agency for International Development
  • Swedish International Development Cooperation Agency

Zitieren

APA

Harryparsad, R., Meyer, B., Taku, O., Serrano, M., Chen, P. L., Gao, X., Williamson, A. L., Mehou-Loko, C., d'Hellencourt, F. L., Smit, J., Strauss, J., Nanda, K., Ahmed, K., Beksinska, M., Buck, G., Morrison, C., Deese, J., & Masson, L. (2023). Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives. PLOS ONE. https://doi.org/10.1371/journal.pone.0294285

Vancouver

Harryparsad R, Meyer B, Taku O, Serrano M, Chen PL, Gao X, et al. Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives. PLOS ONE. 2023. doi:10.1371/journal.pone.0294285

BibTeX
@article{Harryparsad2023,
  author = {Harryparsad, Rushil and Meyer, Bahiah and Taku, Ongeziwe and Serrano, Myrna and Chen, Pai Lien and Gao, Xiaoming and Williamson, Anna-Lise and Mehou-Loko, Celia and d'Hellencourt, Florence Lefebvre and Smit, Jennifer and Strauss, Jerome and Nanda, Kavita and Ahmed, Khatija and Beksinska, Mags and Buck, Gregory and Morrison, Charles and Deese, Jennifer and Masson, Lindi},
  title = {Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0294285}
}
Kostenlos starten →